Share on StockTwits

Immunodiagnostic Systems Hldgs PLC (LON:IDH)‘s stock had its “hold” rating restated by investment analysts at FinnCap in a note issued to investors on Tuesday. They currently have a GBX 450 ($7.66) target price on the stock. FinnCap’s target price would indicate a potential downside of 16.12% from the stock’s previous close.

Immunodiagnostic Systems Hldgs PLC (LON:IDH) traded up 0.28% on Tuesday, hitting GBX 536.50. The stock had a trading volume of 73,296 shares. Immunodiagnostic Systems Hldgs PLC has a 52 week low of GBX 384.00 and a 52 week high of GBX 593.00. The stock has a 50-day moving average of GBX 504.3 and a 200-day moving average of GBX 526..

The company also recently announced a dividend, which is scheduled for Friday, August 22nd. Stockholders of record on Wednesday, July 23rd will be paid a dividend of GBX 8.50 ($0.14) per share. This represents a dividend yield of 1.57%. The ex-dividend date is Wednesday, July 23rd.

A number of other firms have also recently commented on IDH. Analysts at Canaccord Genuity raised their price target on shares of Immunodiagnostic Systems Hldgs PLC from GBX 459 ($7.81) to GBX 492 ($8.37) in a research note on Thursday, June 19th. They now have a “hold” rating on the stock. Separately, analysts at Nplus1 Brewin reiterated a “hold” rating on shares of Immunodiagnostic Systems Hldgs PLC in a research note on Wednesday, April 30th. They now have a GBX 504 ($8.58) price target on the stock. Finally, analysts at N+1 Singer reiterated a “hold” rating on shares of Immunodiagnostic Systems Hldgs PLC in a research note on Wednesday, April 30th. They now have a GBX 504 ($8.58) price target on the stock. Six investment analysts have rated the stock with a hold rating, The stock has an average rating of “Hold” and a consensus target price of GBX 492.33 ($8.38).

Immunodiagnostic Systems Holdings plc (LON:IDH) is engaged in manufacturing and distributing medical diagnostic products.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.